Wealth Management Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.16M Buy
1,802
+589
+49% +$602K 0.51% 44
2026
Q1
$1.12M Sell
1,213
-24
-2% -$24.3K 0.32% 66
2025
Q4
$1.33M Buy
1,237
+18
+1% +$17.2K 0.38% 56
2025
Q3
$930K Buy
1,219
+32
+3% +$23.8K 0.3% 70
2025
Q2
$917K Sell
1,187
-60
-5% -$46.6K 0.32% 67
2025
Q1
$1.03M Sell
1,247
-100
-7% -$83.2K 0.48% 49
2024
Q4
$1.04M Buy
1,347
+34
+3% +$28.2K 0.45% 53
2024
Q3
$1.16M Sell
1,313
-145
-10% -$130K 0.54% 42
2024
Q2
$1.32M Sell
1,458
-115
-7% -$92K 0.64% 36
2024
Q1
$1.22M Sell
1,573
-69
-4% -$49.1K 0.62% 36
2023
Q4
$957K Buy
1,642
+22
+1% +$12.8K 0.53% 45
2023
Q3
$870K Hold
1,620
0.54% 41
2023
Q2
$760K Hold
1,620
0.48% 46
2023
Q1
$556K Sell
1,620
-380
-19% -$128K 0.39% 57
2022
Q4
$593K Hold
2,000
0.49% 47
2022
Q3
$586K Hold
2,000
0.52% 48
2022
Q2
$618K Hold
2,000
0.54% 45
2022
Q1
$574K Hold
2,000
0.41% 54
2021
Q4
$554K Sell
2,000
-177
-8% -$44.9K 0.38% 59
2021
Q3
$503K Hold
2,177
0.37% 59
2021
Q2
$500K Buy
2,177
+292
+15% +$58.7K 0.35% 64
2021
Q1
$344K Hold
1,885
0.26% 81
2020
Q4
$401K Buy
+1,885
New +$281K 0.31% 73

Other funds holding LLY

Wealth Management Partners's LLY Position: Q2 2026 in Review

Wealth Management Partners increased its Eli Lilly (LLY) stake by 49% in Q2 2026, buying an estimated $602K and bringing the position to 1,802 shares worth $2.16M. The position accounts for 0.51% of the portfolio, ranked #44.

Wealth Management Partners first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. 1,716 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wealth Management Partners held 1,802 shares of Eli Lilly worth $2.16M as of Q2 2026.
  • Wealth Management Partners bought 589 Eli Lilly shares in Q2 2026, an estimated $602K.
  • Eli Lilly made up 0.51% of Wealth Management Partners's portfolio in Q2 2026, its #44 holding.
  • Wealth Management Partners first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • 1,716 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wealth Management Partners's 13F filing for Q2 2026, filed 22 Jul 2026.